A 34-year study links early weight loss in prediabetes to lower cardiovascular risks. Explore the findings and what they mean for prevention.
Read More »The Immune Target Moved, but the Diabetes Didn’t: What a Failed Type 1 Trial Can Teach Us
Interleukin-2 boosted immune cells but failed to preserve insulin production in the DIABIL-2 trial. Discover what this means for type 1 diabetes.
Read More »Diabetes Hospitalizations Aren’t Just About Heart and Kidney Disease Anymore
Explore why diabetes hospitalizations involve more than heart and kidney disease, including infections, respiratory illness, and mental health.
Read More »This Insulin Pump Recall Could Affect More Than Convenience
Learn why MiniMed Flex insulin pumps were recalled, the potential insulin delivery risks, and what affected users should do to stay safe.
Read More »After DKA or Repeated Low Blood Sugar, Could Attention Problems Linger?
Explore how hypoglycemia and DKA may be linked to attention difficulties in children with type 1 diabetes and what new research reveals.
Read More »Could Fenofibrate Slow Diabetic Eye Disease in Type 1 Diabetes?
Can fenofibrate slow diabetic retinopathy in type 1 diabetes? Explore new LENS trial research, potential benefits, safety, and clinical implications.
Read More »Quit Smoking, Protect More Than Your Heart: When Diabetes Complication Risk Starts to Fall
New research links smoking cessation to lower diabetes complication risks. Explore what the findings mean for kidney, eye, and nerve health.
Read More »High Altitude, Low Oxygen, Same CGM? Researchers Put Sensor Accuracy to the Test
New research examines CGM accuracy in hypoxia, including Dexcom G6 and FreeStyle Libre performance during reduced oxygen exposure.
Read More »Three Weeks of Treatment, Months of Better Glucose? A New Diabetes Drug Is Testing an Unusual Idea
Early Phase 1b data suggest balomenib may improve glucose control after treatment ends. Learn what the results could mean for type 2 diabetes.
Read More »Pivot Just Got an FDA Update—Here’s What Actually Changed
The Pivot Insulin Delivery System received a new FDA clearance in September 2026. Learn what changed and what clinicians should know.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.